A Physiological Microfluidic Blood–Brain‐Barrier Model for In Vitro Study of Nanoparticle Trafficking and Accumulation
Advanced Healthcare Materials · 2026-05 · 15 (19)
DOI: 10.1002/adhm.202600019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 21.03.2026. Verfasst von Bryan B Nguyen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of California, Davis, USA. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Nanoparticles, Microfluidics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, National Institute of Heart, Lung, and Blood Institution, NIEHS NIH HHS.
Abstract (Originalsprache)
Although the blood–brain barrier (BBB) restricts passage of most molecules, various naturally occurring and synthetic nanoparticles (NPs) are nonetheless found within the brain parenchyma. To study the mechanisms underlying this phenomenon, we developed a microfluidic BBB model (mBBB) using human cerebral microvascular endothelial cells (HCMECs) in direct contact with primary human astrocytes and pericytes within a physiologically relevant extracellular matrix. The horizontal architecture enables high‐resolution imaging across the full barrier interface and allows direct assessment of nanoparticle transport and accumulation. This in vitro platform recapitulates key features of the BBB, including selective permeability, junctional protein expression, and receptor‐mediated uptake pathways. Using this system, the trafficking and accumulation of structurally distinct nanoparticles, including liposomes, nanoplastics, and extracellular vesicles (EVs), were compared. Among these, heterologous EVs exhibit the highest transport efficiency. Analysis of nanoparticle properties suggest that ligand presentation and membrane composition, rather than size or stiffness, primarily govern BBB penetration. The mBBB platform provides a high‐throughput, imaging‐based framework to systematically interrogate nanoparticle trafficking across the BBB and offers a translational tool for both drug delivery and neurotoxicity screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, University of California, Davis, USA.
ORCID-Profile: Bryan B Nguyen, Neona M Lowe, Kuan-Wei Huang, Hannah O'Toole, Elizabeth J Hale, Venktesh S Shirure, Bhupinder S Shergill, Steven C George, Randy P Carney
Förderung
- NIH HHS
- National Institute of Heart, Lung, and Blood Institution
- NIEHS NIH HHS
- College of Biosciences
- Office of Research and the Provost's Office
- Department of Molecular and Cellular Biology
- College of Biological Sciences
- College of Engineering Next Level Research Seed Funding
Zitieren
APA
Nguyen, B. B., Lowe, N. M., Kellogg, S., Huang, K. W., O'Toole, H., Hale, E. J., Shirure, V. S., Shergill, B. S., George, S. C., & Carney, R. P. (2026). A Physiological Microfluidic Blood–Brain‐Barrier Model for In Vitro Study of Nanoparticle Trafficking and Accumulation. Advanced Healthcare Materials, 15(19). https://doi.org/10.1002/adhm.202600019
Vancouver
Nguyen BB, Lowe NM, Kellogg S, Huang KW, O'Toole H, Hale EJ, et al. A Physiological Microfluidic Blood–Brain‐Barrier Model for In Vitro Study of Nanoparticle Trafficking and Accumulation. Advanced Healthcare Materials. 2026;15(19). doi:10.1002/adhm.202600019
BibTeX
@article{Nguyen2026,
author = {Nguyen, Bryan B and Lowe, Neona M and Kellogg, Sophia and Huang, Kuan-Wei and O'Toole, Hannah and Hale, Elizabeth J and Shirure, Venktesh S and Shergill, Bhupinder S and George, Steven C and Carney, Randy P},
title = {A Physiological Microfluidic Blood–Brain‐Barrier Model for In Vitro Study of Nanoparticle Trafficking and Accumulation},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {19},
doi = {10.1002/adhm.202600019}
}
EUVIMED